CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 66.31 CNY 0.26% Market Closed
Market Cap: 10.8B CNY

Wall Street
Price Targets

Price Targets Summary
CanSino Biologics Inc

Wall Street analysts forecast CanSino Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 69.76 CNY with a low forecast of 67.4 CNY and a high forecast of 75.31 CNY.

Lowest
Price Target
67.4 CNY
2% Upside
Average
Price Target
69.76 CNY
5% Upside
Highest
Price Target
75.31 CNY
14% Upside
CanSino Biologics Inc Competitors:
Price Targets
DHG
Dhg Pharmaceutical Joint-Stock Co
6% Upside
603520
Zhejiang Starry Pharmaceutical Co Ltd
48% Upside
ACUTAAS
Acutaas Chemicals Ltd
13% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
14% Upside
GTII
Green Thumb Industries Inc
103% Upside
WEED
Canopy Growth Corp
148% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
40% Upside
IPCALAB
IPCA Laboratories Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
CanSino Biologics Inc

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CanSino Biologics Inc's stock price target?
Price Target
69.76 CNY

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 69.76 CNY with a low forecast of 67.4 CNY and a high forecast of 75.31 CNY.

What is CanSino Biologics Inc's Revenue forecast?
Projected CAGR
28%

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 3 years is 28%.

Back to Top